Prof. Andrei Surguchov

Email: [email protected]

Qualifications

Ph.D., Moscow University, Molecular Biology

Publications (Selected)

1. Surguchov, A., & Surguchev, A. A. (2024). Association between Parkinson’s disease and cancer: new findings and possible mediators. International Journal of Molecular Sciences, 25(7), 3899.
2. Surguchov A. (2024). Nuclear α-synuclein regulates transcription and affects neuronal differentiation. FEBS  J, 291 (9):1886-1888. doi: 10.1111/febs.17072.
   
3. Surguchov, A., Emamzadeh, F. N., Titova, M., & Surguchev, A. A. (2023). Controversial properties of amyloidogenic proteins and peptides: New data in the COVID era. Biomedicines, 11(4), 1215.
4. Surguchov, A. (2023). α-Synuclein and mechanisms of epigenetic regulation. Brain Sciences, 13(1), 150.
5. Surguchov, A., & Surguchev, A. (2022). Synucleins: new data on misfolding, aggregation and role in diseases. Biomedicines, 10(12), 3241.
6. Surguchov, A. (2021). Biomarkers in Parkinson’s disease. In Neurodegenerative diseases biomarkers: Towards translating research to clinical practice (pp. 155-180). New York, NY: Springer US.
7. Surguchov, A. (2021). Biomarkers in Parkinson’s disease. In Neurodegenerative diseases biomarkers: Towards translating research to clinical practice (pp. 155-180). New York, NY: Springer US.
8. Surguchov, A. (2021). Invertebrate models untangle the mechanism of neurodegeneration in Parkinson’s disease. Cells, 10(2), 407.
9. Surguchov, A. (2020). Caveolin: a new link between diabetes and AD. Cellular and molecular neurobiology, 40(7), 1059-1066.
10. Surguchov, A. (2020). Analysis of protein conformational strains—a key for new diagnostic methods of human diseases. International Journal of Molecular Sciences, 21(8), 2801.
11. Surguchev, A. A., & Surguchov, A. (2020). ABCA7—A Member of the ABC Transporter Family in Healthy and Ailing Brain. Brain Sciences, 10(2), 121.
12. Mojbafan, M., Tina, S., Zafarghandi Motlagh, F., Surguchov, A., Nilipour, Y., & Zeinali, S. (2019). Genetic variability in Iranian limb‐girdle muscular dystrophy type 2B patients: An evidence of a founder effect. Molecular Genetics & Genomic Medicine, 7(12), e1029.
13. Surguchov, A., Emamzadeh, F. N., & Surguchev, A. A. (2019). Amyloidosis and longevity: A lesson from plants. Biology, 8(2), 43.
14. Surguchev, A. A., & Surguchov, A. (2019). Integrins—A missing link in synuclein’s pathogenic mechanism. J. Neurosci. Res, 97, 539-542.
15. Surguchev, A. A., Emamzadeh, F. N., & Surguchov, A. (2019). Cell responses to extracellular α-synuclein. Molecules, 24(2), 305.
16. Emamzadeh, F. N., & Surguchov, A. (2018). Parkinson’s disease: biomarkers, treatment, and risk factors. Frontiers in neuroscience, 12, 612.
17. Surguchev, A. A., & Surguchov, A. (2017). Synucleins and gene expression: ramblers in a crowd or cops regulating traffic?. Frontiers in molecular neuroscience, 10, 224.
18. Surguchov, A., Surgucheva, I., Sharma, M., Sharma, R., & Singh, V. (2017). Pore-forming proteins as mediators of novel epigenetic mechanism of epilepsy. Frontiers in Neurology, 8, 3.
19. Roman, A. Y., Kovrazhkina, E. A., Razinskaya, O. D., Kukharsky, M. S., Maltsev, A. V., Ovchinnikov, R. K., ... & Skvortsova, V. I. (2017, January). Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders. In Doklady Biochemistry and Biophysics (Vol. 472, pp. 64-67). Pleiades Publishing.
20. Surguchov, A. (2016). Parkinson’s disease: assay of phosphorylated α-synuclein in skin biopsy for early diagnosis and association with melanoma. Brain Sciences, 6(2), 17.
21. Surguchev, A., & Surguchov, A. (2015). Effect of α‐synuclein on membrane permeability and synaptic transmission: a clue to neurodegeneration?. Journal of neurochemistry, 132(6), 619-621.

Profile Details

WoS ResearcherID: A-2492-2008

https://www.linkedin.com/in/andre-surguchov-a5231713

https://scholar.google.com.hk/citations?user=BsT6G3cAAAAJ&hl=en

https://www.researchgate.net/profile/Andrei-Surguchov